We provide you with 20 years of free, institutional-grade data for TGTX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TGTX. Explore the full financial landscape of TGTX stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-08 | 1001316 | TGTX | 10-Q | Url |
| 2025-05-09 | 1001316 | TGTX | 10-Q | Url |
| 2025-03-03 | 1001316 | TGTX | 10-K | Url |
| 2024-11-07 | 1001316 | TGTX | 10-Q | Url |
| 2024-08-09 | 1001316 | TGTX | 10-Q | Url |
| 2024-05-06 | 1001316 | TGTX | 10-Q | Url |
| 2024-02-29 | 1001316 | TGTX | 10-K | Url |
| 2023-11-06 | 1001316 | TGTX | 10-Q | Url |
| 2023-08-04 | 1001316 | TGTX | 10-Q | Url |
| 2023-05-08 | 1001316 | TGTX | 10-Q | Url |
| 2023-03-01 | 1001316 | TGTX | 10-K | Url |
| 2022-11-09 | 1001316 | TGTX | 10-Q | Url |
| 2022-08-09 | 1001316 | TGTX | 10-Q | Url |
| 2022-05-10 | 1001316 | TGTX | 10-Q | Url |
| 2022-03-01 | 1001316 | TGTX | 10-K | Url |
| 2021-11-08 | 1001316 | TGTX | 10-Q | Url |
| 2021-08-06 | 1001316 | TGTX | 10-Q | Url |
| 2021-05-10 | 1001316 | TGTX | 10-Q | Url |
| 2021-03-01 | 1001316 | TGTX | 10-K | Url |
| 2020-11-09 | 1001316 | TGTX | 10-Q | Url |
| 2020-08-10 | 1001316 | TGTX | 10-Q | Url |
| 2020-05-11 | 1001316 | TGTX | 10-Q | Url |
| 2020-03-02 | 1001316 | TGTX | 10-K | Url |
| 2019-11-12 | 1001316 | TGTX | 10-Q | Url |
| 2019-08-09 | 1001316 | TGTX | 10-Q | Url |
| 2019-05-10 | 1001316 | TGTX | 10-Q | Url |
| 2019-03-01 | 1001316 | TGTX | 10-K | Url |
| 2018-11-09 | 1001316 | TGTX | 10-Q | Url |
| 2018-08-09 | 1001316 | TGTX | 10-Q | Url |
| 2018-05-10 | 1001316 | TGTX | 10-Q | Url |
| 2018-03-15 | 1001316 | TGTX | 10-K | Url |
| 2017-11-09 | 1001316 | TGTX | 10-Q | Url |
| 2017-08-09 | 1001316 | TGTX | 10-Q | Url |
| 2017-05-10 | 1001316 | TGTX | 10-Q | Url |
| 2017-03-16 | 1001316 | TGTX | 10-K | Url |
| 2016-11-09 | 1001316 | TGTX | 10-Q | Url |
| 2016-08-09 | 1001316 | TGTX | 10-Q | Url |
| 2016-05-10 | 1001316 | TGTX | 10-Q | Url |
| 2016-03-15 | 1001316 | TGTX | 10-K | Url |
| 2015-11-09 | 1001316 | TGTX | 10-Q | Url |
| 2015-08-10 | 1001316 | TGTX | 10-Q | Url |
| 2015-05-11 | 1001316 | TGTX | 10-Q | Url |
| 2015-03-16 | 1001316 | TGTX | 10-K | Url |
| 2014-11-14 | 1001316 | TGTX | 10-Q | Url |
| 2014-07-24 | 1001316 | TGTX | 10-Q | Url |
| 2014-05-14 | 1001316 | TGTX | 10-Q | Url |
| 2014-03-07 | 1001316 | TGTX | 10-K | Url |
| 2013-11-14 | 1001316 | TGTX | 10-Q | Url |
| 2013-08-09 | 1001316 | TGTX | 10-Q | Url |
| 2013-05-14 | 1001316 | TGTX | 10-Q | Url |
| 2013-03-21 | 1001316 | TGTX | 10-K | Url |
| 2012-11-14 | 1001316 | TGTX | 10-Q | Url |
| 2012-08-09 | 1001316 | TGTX | 10-Q | Url |
| 2012-05-14 | 1001316 | TGTX | 10-Q | Url |
| 2012-03-14 | 1001316 | TGTX | 10-K | Url |
| 2011-11-14 | 1001316 | TGTX | 10-Q | Url |
| 2011-08-15 | 1001316 | TGTX | 10-Q | Url |
| 2011-05-16 | 1001316 | TGTX | 10-Q | Url |
| 2011-03-31 | 1001316 | TGTX | 10-K | Url |
| 2010-11-15 | 1001316 | TGTX | 10-Q | Url |
| 2010-08-16 | 1001316 | TGTX | 10-Q | Url |
| 2010-06-07 | 1001316 | TGTX | S-1 | Url |
| 2010-05-24 | 1001316 | TGTX | 10-Q | Url |
| 2010-03-31 | 1001316 | TGTX | 10-K | Url |
| 2009-11-16 | 1001316 | TGTX | 10-Q | Url |
| 2009-08-14 | 1001316 | TGTX | 10-Q | Url |
| 2009-06-02 | 1001316 | TGTX | S-1 | Url |
| 2009-05-15 | 1001316 | TGTX | 10-Q | Url |
| 2009-03-31 | 1001316 | TGTX | 10-K | Url |
| 2009-02-23 | 1001316 | TGTX | S-1 | Url |
| 2008-11-19 | 1001316 | TGTX | 10-Q | Url |
| 2008-08-19 | 1001316 | TGTX | 10-Q | Url |
| 2008-05-20 | 1001316 | TGTX | 10-Q | Url |
| 2008-05-01 | 1001316 | TGTX | S-1 | Url |
| 2008-03-31 | 1001316 | TGTX | 10-K | Url |
| 2007-11-14 | 1001316 | TGTX | 10-Q | Url |
| 2007-08-14 | 1001316 | TGTX | 10-Q | Url |
| 2007-05-15 | 1001316 | TGTX | 10-Q | Url |
| 2001-08-20 | 1001316 | TGTX | 10-Q | Url |
| 1996-11-07 | 1001316 | TGTX | 10-Q | Url |
TG Therapeutics, Inc(NASDAQ:TGTX) 
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclon...
Website: http://www.tgtherapeutics.com
Founded: 1993
Full Time Employees: 217
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about TGTX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.